RF
Fish, Richard
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Composition of thrombi in zebrafish : similarities and distinctions with mammals | Journal of thrombosis and haemostasis |  | 2024 | 136 | 0 | ||
| Regulation of fibrinogen synthesis | Thrombosis research | | 2024 | 33 | 0 | ||
| Hemostasis and thrombosis in the zebrafish: a vertebrate model for human coagulopathies | | 2023 | 123 | 9 | |||
| The XRN1-regulated RNA helicase activity of YTHDC2 ensures mouse fertility independently of m6A recognition | Molecular cell |  | 2022 | 60 | 79 | ||
| Chemical modulators of fibrinogen production and their impact on venous thrombosis | Thrombosis and Haemostasis | | 2021 | 227 | 169 | ||
| Fibrin(ogen) in human disease: both friend and foe | Haematologica | | 2020 | 409 | 256 | ||
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | | 2020 | 271 | 227 | ||
| A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis | Blood Advances | | 2020 | 184 | 94 | ||
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | | 2020 | 212 | 53 | ||
| Local chromatin interactions contribute to expression of the fibrinogen gene cluster | Journal of Thrombosis and Haemostasis | | 2018 | 512 | 158 | ||
| Inactivation of AMMECR1 is associated with growth, bone, and heart alterations | Human Mutation | | 2018 | 557 | 255 | ||
| KIAA1109 Variants Are Associated with a Severe Disorder of Brain Development and Arthrogryposis | American Journal of Human Genetics | | 2018 | 539 | 297 | ||
| The effect of genetic variation on promoter usage and enhancer activity | Nature Communications | | 2017 | 342 | 153 | ||
| tfec controls the hematopoietic stem cell vascular niche during zebrafish embryogenesis | Blood | | 2016 | 540 | 9 | ||
| GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability | American journal of human genetics | | 2016 | 643 | 377 | ||
| Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques | PloS one | | 2016 | 526 | 203 | ||
| Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes | Genomics | | 2015 | 611 | 4 | ||
| Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes | Data in brief | | 2015 | 659 | 266 | ||
| C2orf62 and TTC17 are involved in actin organization and ciliogenesis in zebrafish and human | PloS one | | 2014 | 650 | 353 | ||
| Targeted mutation of zebrafish fga models human congenital afibrinogenemia | Blood | | 2014 | 666 | 5 | ||
| DNA Methylation Profiling of the Fibrinogen Gene Landscape in Human Cells and during Mouse and Zebrafish Development | PloS one | | 2013 | 652 | 320 | ||
| Fibrinogen gene regulation | Thrombosis and haemostasis | | 2012 | 734 | 3 | ||
| Developmental expression and organisation of fibrinogen genes in the zebrafish | Thrombosis and haemostasis | | 2012 | 708 | 7 | ||
| A novel regulatory element between the human FGA and FGG genes | Thrombosis and haemostasis | | 2012 | 653 | 0 | ||
| A liver enhancer in the fibrinogen gene cluster | Blood | | 2011 | 629 | 3 | ||
| Regulation of the endothelial plasminogen activator system by fluvastatin. Role of Rho family proteins, actin polymerisation and p38 MAP kinase | Thrombosis and haemostasis | | 2011 | 585 | 325 | ||
| Regulation of fibrinogen production by microRNAs | Blood | | 2010 | 593 | 0 | ||
| Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A' | Thrombosis and haemostasis | | 2010 | 601 | 272 | ||
| Generation of human inflammation-resistant endothelial progenitor cells by A20 gene transfer | Journal of vascular research | | 2010 | 617 | 0 | ||
| Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | | 2008 | 633 | 8 | ||
| Retinoids and activation of PKC induce tissue-type plasminogen activator expression and storage in human astrocytes | Journal of thrombosis and haemostasis | | 2008 | 646 | 0 | ||
| Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model | Cancer gene therapy | 2008 | 522 | 0 | |||
| Role of Gas6 in erythropoiesis and anemia in mice | The Journal of clinical investigation | | 2008 | 689 | 174 | ||
| Characterization of endothelial-like cells derived from human mesenchymal stem cells | Journal of thrombosis and haemostasis | | 2007 | 566 | 0 | ||
| Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques | Thrombosis and haemostasis | | 2007 | 564 | 175 | ||
| Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues | Biochemical journal | | 2007 | 609 | 291 | ||
| Gene conversion limits divergence of mammalian TLR1 and TLR6 | BMC evolutionary biology | | 2007 | 580 | 269 | ||
| Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells | Stem cells |  | 2006 | 564 | 0 | ||
| Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis | Experimental cell research | | 2006 | 627 | 459 | ||
| Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies | Thrombosis and haemostasis | | 2005 | 670 | 310 | ||
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | | 2004 | 670 | 1 | ||
| Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors | BMC molecular biology | | 2004 | 585 | 201 | ||
| Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES | Antimicrobial agents and chemotherapy | | 2003 | 623 | 6 |
